• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz

By: The Law Offices of Frank R. Cruz via Business Wire
October 22, 2025 at 19:42 PM EDT

The Law Offices of Frank R. Cruz announces an investigation of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAXTER INTERNATIONAL, INC. (BAX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On April 7, 2025, a Missouri news outlet reported serious safety issues relating to inaccurate infusion rates with Baxter’s Novum IQ Large Volume Pump (“Novum LVP”), a device used for the controlled delivery of intravenous fluids, based on information from a whistleblower at a local hospital system. The whistleblower claimed that “patients should not be being treated with these pumps. These pumps are not safe.” The report led to the hospital system’s removal of all Novum LVPs.

Then, on April 24, 2025, Baxter sent warning letters to customers regarding a potential underinfusion risk associated with the Novum LVP, disclosing only one serious injury linked to this issue. On July 14, 2025, the Company issued a second warning letter repeating the underinfusion risk along with an additional overinfusion risk, revealing that it had received 79 reports of serious injury and two reports of patient deaths related to the Novum LVP. The FDA subsequently classified these issues as a Class I recall, its most serious designation, reflecting a risk of severe injury or death.

Then, on July 31, 2025, Baxter announced that it was “voluntarily and temporarily [pausing] shipments and planned installations of the Novum LVP” and that the Company was “unable to currently commit to an exact timing for resuming shipment and installation for Novum LVPs.”

On this news, Baxter’s stock price fell $6.24, or 22.4%, to close at $21.61 per share on July 31, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased Baxter securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251022463112/en/

Contacts

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz

310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com

More News

View More
3 Stocks With Big Dividend Hikes—and Bigger Momentum
Today 14:15 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers APH FIX MCD SBUX
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data
Today 13:34 EDT
Via MarketBeat
Tickers RPRX ZBIO
Will D-Wave's Federal Government Boost Last?
Today 12:27 EDT
Via MarketBeat
Tickers QBTS
NVIDIA to Rise by Another 50%? Analyst Trends Say Yes
Today 11:10 EDT
Via MarketBeat
Tickers NVDA
Buyback Accelerators: 3 Stocks Boosting Capacity & Spending Speed
Today 10:35 EDT
Via MarketBeat
Tickers BCS COF EPAM

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.30
+3.33 (1.47%)
AAPL  269.06
+0.25 (0.09%)
AMD  260.23
+0.56 (0.22%)
BAC  52.70
-0.32 (-0.59%)
GOOG  268.64
-1.29 (-0.48%)
META  755.33
+4.51 (0.60%)
MSFT  542.55
+11.03 (2.08%)
NVDA  198.07
+6.58 (3.44%)
ORCL  284.74
+3.34 (1.19%)
TSLA  460.36
+7.94 (1.76%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap